AirRadar.pro

Novo Nordisk A/S

NVO
$38.83−1.27% 1D
$224.2552-week range$409.95

Updated . Prices are snapshots and may be delayed.

Open full workspace

Novo Nordisk A/S price chart

+0.09% over 7D
$39.60
$38.03
Oct 18
Oct 20

AI Outlook for Novo Nordisk A/S

Bearish posture
  • Long-term trend
    -14.6% vs 200-day average
  • Medium-term trend
    -9.7% vs 50-day average
  • Averages
    50-day below 200-day
  • 3 more trend and momentum checks
  • Nearby support and resistance levels
  • What would strengthen or weaken the picture
See plans to unlockOpen NVO in the workspace

Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out

Novo Nordisk A/S performance

1D
−1.3%
7D
−0.4%
30D
−11.2%
90D
−22.2%
1Y
−27.5%

About Novo Nordisk A/S

Novo Nordisk A/S is a pharmaceuticals company based in Denmark, listed on OMX NORDIC EXCHANGE COPENHAGEN A/S since 1974 (ticker NVO).

The shares trade at a price-to-earnings ratio of 9.5. The dividend yield is 1.00%.

Novo Nordisk A/S market data

What is the price of Novo Nordisk A/S today?

Novo Nordisk A/S (NVO) is at $38.83, −1.27% on the day.

What is the 52-week range of Novo Nordisk A/S?

Over the past year Novo Nordisk A/S has traded between $224.25 and $409.95. It is currently -100% of the way up that range.

What is the P/E ratio of Novo Nordisk A/S?

Novo Nordisk A/S trades at a price-to-earnings ratio of 9.5.

Similar stocks

LLY
Eli Lilly and Co
$1,257.03+0.1%
PFE
Pfizer Inc
$29.58−0.5%
SXTC
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares
$0.065−20.5%
HLN
Haleon plc
$10.13+1.5%
BMY
Bristol-Myers Squibb Company
$59.75−2.2%
MRK
Merck & Co., Inc.
$145.95−0.7%
VTRS
Viatris Inc.
$18.66+2.5%
SDEV
Stablecoin Development Corporat
$0.8808−12.8%

Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.